Download Challenging cases in Vulvar Dermatology UCI Handout No Pictures

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Systemic scleroderma wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Behçet's disease wikipedia , lookup

Transcript
Challenging Cases in Dermatology:
The Itchy, Painful or Burning Vulva
Ginat W. Mirowski, DMD, MD
Department of Oral Pathology, Medicine, Radiology
Department of Dermatology
Indiana University
Full Disclosure of Faculty Financial Interests or
Relationships
I agree to follow the UIC and ACCME policies and declare that I do
not have a financial interest or other relationship with any
manufacturers of any commercial products that may be discussed
during this presentation.
1
Conflict of Interest
•  I have no relevant conflicts of interest
•  I will discuss use of off label medications
•  The medications and treatment suggestions
mentioned in this talk are based on my current
use patterns; other treatment options may be
available
Vulvar Dermatology
Objectives
•  Present a dermatologist’s approach to the
patient with vulvar complaints
•  Itch
•  Pain
•  Burning
•  Share clinical pearls for diagnosis
•  Discuss systemic considerations
2
Vulvar Dermatology
Therapeutic Objectives
•  Review treatment pearls related to vulvar
dermatology
•  Discuss treatment regimens
•  topical regimens
•  systemic regimens
•  supportive care
•  Underscore potential hazards and
obstacles to maximize therapeutic success
Have confidence!!
•  Vulvar diseases can be challenging
•  Vulvar patients can be frustrated
•  Treatment of vulvar
disease may be
challenging
•  But…success is possible
and very much
achievable
3
Evaluation of Patient with
Vulvar Concerns
•  Identify potential etiologies and exacerbating
factors
•  Medical history and review of systems
•  Identify extent of involvement and impact
•  Directed physical examination skin and mucous
membranes
•  Treat and eliminate confounding conditions
•  Remove all potential local irritants
Pruritus Vulva
(partial list of dermatologic and infectious causes)
• 
• 
• 
• 
• 
• 
• 
• 
• 
Eczematous dermatitis
Lichen sclerosus
Lichen planus
Psoriasis
Contact dermatitis
Dermatophyte infection
Paget’s disease
Syringomas
Squamous cell carcinoma
•  Candidiasis (erythematous
and pseudomembranous)
•  Beta strep
•  Secondary syphilis
•  Pityriasis rosea
•  Discoid lupus
erythematosus
•  Diabetes
•  Hepatic failure
•  Iron deficiency anemia
•  Hypothyroidism
4
Vulvar Examination
Pearls and Pitfalls
• 
• 
• 
• 
• 
• 
• 
Clinician and patient à comfortable
Engage patient with eye contact & hand mirror
Moisture alters the appearance
Gently pat with gauze to dry off the mucosa
Minor trauma alters the primary morphology
Limited number of reaction patterns
Histology is not specific but often helpful
Complete Mucocutaneous Exam*
•  Skin, hair, nails
•  Oral and ocular mucous membranes inc
conjunctiva, esophagus, larynx, ears
•  Vulvar exam
•  Vaginal exam with speculum; wet mount
•  Patient participation
* often requires consultation referral
5
Start at the Top! Work to Inside!
The Normal Vulva
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Abdomen, thighs
Mons or mons pubis
Clitoral hood, clitoris
Labia majora or outer labia
Interlabial sulcus
Labia minora or inner labia
Vaginal introitus/vestibule
Posterior fourchette
Perineal body/perineum
Perianal area, buttocks
Gluteal cleft
Illustrated by Dawn Danby and Paul Waggoner
Challenging Vulvar Cases:
Pruritic, Painful or Burning Vulva
•  Primary or essential
à no primary etiology
identified
•  Secondary à infections,
dermatoses, systemic
diseases, malignancy,
or neurologic conditions
•  Multifactorial or mixed
Primary
Secondary
(essential)
Mixed
6
Eczematous (Vulvar) Dermatitis
•  External sensation of itching
•  Need to scratch or rub
•  Skin thickens à prominent skin fold markings
(lichenification)
•  Excoriations /pigmentary changes
•  Psychologically distressing
•  Socially embarrassing
Eczematous Dermatitis
Clinical Features
•  Poorly demarcated plaques
•  Variable
erosions
excoriations
erythema
pigmentary change
•  Severe pruritus
•  Lichenification
7
Eczematous Vulvar Dermatitis
Aggravating Factors
•  Body fluids (sweat,
urine, feces)
•  Excessive bathing
(soaps, detergents,
bubble baths, douche)
•  Tampons/pads
•  Condoms/spermicidal
agents
• 
• 
• 
• 
Feminine hygiene products
Lubricants
Toilet paper
Medications
•  antifungals/antibiotics
•  corticosteroids
•  hormones
•  others
Candidiasis
Clinical pearls
•  Common in both
children and adults
•  Erythematous plaques
•  Satellite papules
•  Edema of labia
•  +/- discharge
•  Intertrigo - erosive
8
Evaluation:
KOH Microscopy
•  Confirm at bedside
•  Pseudohyphae
–  Doubly refractile
–  Tapering at ends
–  Branching
•  Budding yeast – bowling pins
Challenging Unknown:
Red Itchy Vulva
9
Cutaneous Psoriasis
•  2-5% in general population
•  Sharply demarcated
erythematous papules and plaques
with silvery scale
•  Symptoms: absent to severe pruritus
•  Findings: Scalp, elbows, and knees >
Intergluteal cleft pinking
•  Rarely entire skin surface is affected
•  Nail involvement ~ 50% of patients
Psoriasis
•  Papulosquamous eruption; joint involvement
•  May occur at any age; onset is usually gradual
•  Cellular turnover is increased sevenfold and
decreased from the normal 28 days to 3 or 4 days
•  + family history in 1/3; genetic predisposition
•  Precipitated by infection, trauma, or stress
•  Exacerbated by beta blockers and lithium
10
Vulvar Psoriasis
• Well-circumscribed
• Pink plaques
• Little to no scale
• Inguinal crease,
intergluteal fold, mons
pubis, labia majora,
perineum
• Symptoms vary from
absent to severe pruritus
Vulvar Psoriasis
•  Pink patches
•  No satellite lesions
•  D/dx: Candidiasis,
intertrigo, seborrheic
dermatitis
•  Secondarily infected
candida, strep
11
Candidiasis vs Psoriasis
• 
• 
• 
• 
Common
Erythematous plaques
Satellite papules
Extra vaginal, Intertrigo –
erosive, edema
•  Rare in children
•  Erythematous patches
•  Extravaginal
•  Intertrigo
•  Gluteal pinking
Dermatophytosis
“Jock itch” or Tinea Cruris
• Papulosquamous
eruption
• Infection
• Ring like plaques with
central clearing
• Border - fine scale
• Symptoms variable
• KOH positive
12
Dermatophyte
KOH Preparation
Unknown
Vulvar Pruritus
•  Unresponsive
•  Topical anti-yeast
medications
•  Topical steroids
helped slightly
•  Protopic, Elidel very
irritating
•  Diagnostic biopsy
was performed
13
Lichen Planus
•  Chronic pruritic mucocutaneous dermatosis
•  Polygonal purple papules, flat topped
•  Wrists and ankles > mucous membranes
•  Unknown etiology
•  A cellular immune mechanism is suspected
•  Activated T-cells seen in early lesionsà
Target antigenically altered basal cells
•  Suppressor T-cells predominate in older lesions
Lichen Planus Incidence
• 
• 
• 
• 
• 
• 
In US 0.44%
In dermatology clinics 1.5%
Oral medicine clinics 5%
No such number in GYN clinic
Oral disease 1/2000
Genital involvement 1/4000 – 1/8000
14
Cutaneous Lichen Planus
Pruritic polygonal flat topped purple or pink papules
Oral Lichen Planus
•  Reticulated white plaque (net-like)
•  Buccal mucosa > gingivae or tongue
•  Usually asymptomatic
•  Erosive à painful
•  D/Dx: LP, PV, BP
•  Biopsy diagnostic
15
Genital
Lichen Planus
• 
• 
• 
• 
Women >> men
Waxing & waning
Decades
Mistaken for
recurrent
“Candida” or
“Herpes”
•  5th - 6th decade, all ages
Vulvovaginal Lichen Planus
•  White, lacey papules (reticulated plaque)
•  Erosion
16
Erosive Vulvar Lichen Planus
Prospective study n = 114 women x 5 yrs
Presenting signs
•  Erosions (90%)
•  White reticulations
(82%) (may be
asymptomatic)
•  Hypertrophic
changes (20-25%)
Presenting symptoms
•  Pain (80%)
•  Pruritus (65%)
•  Dyspareunia (61%)
•  Irritation (48%)
Cooper and Wojnarowska, Arch Derm 2006
Vulvovaginal Scarring in Lichen Planus
• Burying of the clitoris
• Loss of the right labium
minus
• Agglutination/
resorption of the labium
minora
• Vaginal adhesions and
stenosis
• Pink perirectal papules
Bethanee Schlosser
17
Vulvovaginal Gingival Syndrome
Vulvar Scarring
Loss of labia minora
Burring of clitoris
Vaginal scarring
Oral and gingiva findings
Common
May precede, follow or occur
concurrently
Esophageal Lichen Planus
• 
• 
• 
• 
• 
Review 72 cases
7:1 women : men
Median age 62 years
Dysphagia 81%
Odynophagia 24%
• 
• 
• 
• 
Oral LP 89%
Vulvar /anal LP 42%
Skin LP 38%
Esophageal disease
•  Proximal 64%
•  Distal 11%
•  Both 26%
Fox, Lightdale, Grossman JAAD 2011; 65:175-83
18
Lichen Planus and Cicatricial
Conjunctivitis
•  Indistinguishable from other
forms of cicatricial
conjunctivitis
•  11 new and 18 published
•  All had other mucosal sites
•  D/dx: pemphigoid, Stevens
Johnson, Atopic
Keratoconjunctivitis
•  Tx: corticosteroid or
cyclosporine drops
Brewer et al. JEADV 2011 25(1):100-4
Lichen Planus
Histology
•  Hyperkeratosis
•  Acanthosis
•  Dyskeratosis
•  Intense band-like
inflammatory infiltrate
•  Hypergranulosis
•  Basal cell liquefaction and
destruction
•  Immunofluorescence +
19
Vulvar Lichen Planus
Clinical Features
•  Think of lichenoid mucositis
secondary to medications
• NSAIA
• Antihypertensive agents
• Long list of other
Lichenoid Drug Reactions
(Partial List)
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Allopurinol
Arsenicals
Aspirin
Bismuth
Carbamazepine
Chloroquine
Chlorothiazide
Chlorpropamide
Dapsone
Furosemide
Gold salts
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Hydroxychloroquine
Imipramine
Interferons
Levamisole
Lithium
Mercury
Methyldopa
Naproxen
Palladium
Para-aminosalicylic acid
Penicillamine
Phenothiazine
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
Phenytoin
Procainamide
Propranolol
Quinacrine
Quinidine
Spironolactone
Streptomycin
Tetracycline
Tolbutamide
Triprolidine
Zidovudine
20
Challenging Case
•  Patient know to have
Lichen Planus
•  Presents for routine
follow-up
•  She reports all is going
well and she is
asymptomatic
•  But… not all is well
Vulvar SCC and LP
•  Occasionally reported
•  Incidence is rare
•  10 of 145 patients had
a genital malignant
neoplasm or a history
of the same
Cooper, Haefner and AbrahamsGessel 2008 Archives of
Dermatology
21
Challenging Unknown
•  Sharply circumscribed
plaques
•  Variable color
pink, brown, blue, white
•  D/dx: SCC/bowens
disease, wart, lichen
simplex chronicus,
psoriasis, lichen
planus, discoid lupus
Unknown
Other mucocutaneous
findings
22
Discoid Lupus Erythematosus
•  Sharply circumscribed
plaques
•  Variable color
pink, brown, blue, white
•  Sun exposed areas
commonly involved
•  When below the waist,
consider systemic
disease (ANA)
Vesiculobullous Diseases
Definition
•  Rare, inherited or acquired diseases
•  Characterized by blisters and ulcers
•  Mucous membranes, skin and systemic
involvement
•  Primary lesions
-->
vesicles and bullae
•  Secondary lesions -->
erythema, erosions,
ulcers, adhesions,
atrophy and scaring
23
Vesiculobullous
and Erosive Diseases
•  Lichen planus
•  Cicatricial pemphigoid
(benign mucous
membrane
pemphigoid
•  Lupus erythematosus
•  Herpes simplex virus
•  Pemphigus
vulgaris
•  Erythema
multiforme
•  Aphthous ulcers
•  Behcet’s
syndrome
Cicatricial Pemphigoid
•  Autoimmune condition
•  Tense bullae or erosions
•  Cutaneous and mucosal
involvement
oral, vulvar, conjunctiva
24
Pemphigus Vulgaris
•  Rare autoimmune
condition
•  Uniformly fatal prior to
advent of steroids
•  Oral involvement early
•  Erosions >> bullae
Pemphigus Vulgaris
Cutaneous Manifestations
•  Flaccid bullae
•  Intraepithelial
acantholysis
•  Follow serum ab levels
•  Ab reflect disease
activity in patients
25
Pemphigus Vulgaris
Pathologic Findings
Atrophic Conditions
• 
• 
• 
• 
Candidiasis
Lichen sclerosus
Post steroid atrophy
Estrogen deficiency
26
Erythematous Candidiasis
•  Erythema and erosions
•  Edema
•  Satellite papules may
be hard to find
•  Discharge is gray
•  KOH may not be
diagnostic
Vulvar Lichen sclerosus
• 
• 
• 
• 
• 
• 
Chronic inflammatory dermatosis
Waxing and waning course
Hallopeau in 1887
Wide clinical spectrum
Pruritus common
Bimodal distribution
(women>girls, men)
•  Unknown etiology
27
Lichen Sclerosus:
Clinical Features
•  White, crinkled lesions; Often
hemorrhagic and eroded
•  Located on the modified
mucous membranes:
vulva, perineum and perianal
•  No vaginal involvement
•  Skin involvement is not
uncommon
Vulvar Lichen Sclerosus:
Clinical Features
•  Hypopigmented atrophic macules or
patches; Scarring is common
•  Genital disease à hemorrhage and
erosions ; May be mistaken for child or
elder abuse
•  "figure eight"
•  Skin lesions in 20%
•  NO vaginal involvement ***
•  Rare oral cases
•  Autoimmune (thyroid,
vitiligo, pernicious anemia)
Cooper et al. Arch Dermatol. 2008;144(11):1432-143
28
Histology of Vulva
Lichen Sclerosus
•  Epithelium is normal
•  Submucosa shows band of
hyalinization of the
underlying dermis
•  (appears structureless,
edematous with few cells)
•  Slight inflammatory band
Lichen Sclerosus
and Increased Risk of Malignancy
• 
• 
• 
• 
• 
SCC<5%; verrucous carcinoma case reports
Vulvar SCC ~ 60% occur on LS background
Even when LS is successfully treated
Life long annual examinations
Biopsy of any nonhealing erosions or papules
that appear
•  http://www.niams.nih.gov/Health_Info/
Jones et al. Am J Obstet Gynecol 2008: 198:496
Lichen_Sclerosus/default.asp
Walkden J Obstet Gynaecol 1997; 17:551–3.
29
Approach to the
Treatment Of Vulvar Disorders
•  Obtain a definitive diagnosis
•  Culture (viral, bacterial, fungal)
•  Biopsy for routine H&E and IF
•  Give yourself and the patient time
•  Remain non-judgmental and supportive
•  Avoid telephone diagnoses
•  Reexamine patient; Obtain cultures; Biopsy
•  Treat one condition at a time (Osler)
Papulosquamous and
Eczematous Disorders
•  Corticosteroids first line treatment
Topical vs. Systemic
Start with super-potent and taper q 2 weeks
bid --> qd --> MWF
•  Steroid sparing agents
•  Symptomatic measures
•  Prophylaxis for secondary infections
Candida, Dermatophyte, Virus
30
Steroid Complications
Stria
HSV
Atrophy
Striae (stretch marks)
Telangiectasias
Secondary infections
Dermatitis
Topical Steroids
Important Issues to Consider
•  Potency of agent
•  Vehicle
•  Affected areas
•  Non-erosive disease on skin --> cream - base
•  Mucosal disease of vulva --> ointment - base
•  Vulvovaginal disease --> applicator, foam,
suppositories
•  Oral disease --> gels or elixir
•  Consider intralesional steroids
31
Supportive Aspect of
Treatment of Vulvar Disorders
•  Address urinary and
fecal incontinence
•  Barrier petrolatum
and zinc based
ointments
•  Use systemic
medications
whenever possible
•  Treat low estrogen
states (postpartum,
peri and post
menopause) with
estrogen to restore
vaginal and vulvar
mucosal barrier
function
Vulvar Pruritus
•  Break the scratch-itch cycle
•  Non-sedating antihistamines in morning
•  Sedating antihistamines at bedtime
•  Hydroxyzine 10-75mg
•  Doxepin 10-30mg
•  Cool compresses, frozen peas (wrapped in a towel)
32
Summary of Therapeutic Tips
•  Ointments are preferred over creams
•  Vulvar disease can be relatively steroid-resistant
•  Use ultra potent steroids
•  Monitor for atrophy at crural crease, thighs, buttocks
•  Limit topicals
•  Use systemic antibiotics, antifungals when available
Multidisciplinary Team
• Nurse practitioner
• Physician assistant
• PCP
• Gynecologist
• Dentist
• Ophthalmologist
• Gastroenterologist
• Urologist
• Psychologist
• Sexual therapist
• Physical therapist
• Marriage
counselor
• Others
Andrew Luck
33
Vulvar Dermatology
•  You are not alone
•  Many patients
believe that the
vulvar dermatitis can
be a devil of a
problem
•  Now you have the
tools to treat it
References
•  Genital Dermatology Atlas by Dr. Libby Edwards
(2010)
•  Obstetric and Gynecologic Dermatology by
Black et al. (2008)
•  Seminars in Cutaneous Medicine and Surgery.
WB Saunders, September (1998)
•  Dermatologic Clinics: Vulvovaginal Dermatology
edited by Dr. Libby Edwards (2010)
•  WWW.ISSVD.ORG
34
Where to Biopsy
•  Histology (H&E)
•  Optimal site is an active
lesion or if ulcerated at the
border (normal and abnormal)
•  Immunofluorescence
•  Optimal site is perilesional
(normal)
35
Immunofluorescence
• 
• 
• 
• 
• 
Laboratory technique
Demonstrates the presence of autoantibodies
Tissues (direct) or serum (indirect)
Normal tissue used as a substrate
Different substrates for specific diseases
General Therapeutic Approach
Vulvar Inflammatory Conditions
•  Eliminate contact with all potential irritants
•  Avoid any chemical or product that could
confound treatment
•  Use systemic regimens if available
•  Start low and go slow
•  Consider supportive care
36
Avoid Topical Agents
• 
• 
• 
• 
Toilet paper
Lotions / creams
Disposable wipes
Feminine deodorant
products / douches
•  Sanitary napkins
•  Tampons
•  Pantyhose and girdles
• 
• 
• 
• 
• 
• 
• 
• 
Suppositories
Soaps
Detergents
Baths
Bubble bath / bath salts
Condoms
Spermicidal agents
Lubricants
What Is Safe?
• 
• 
• 
• 
Water
• 
One’s hands
• 
Cotton towels / diapers
• 
Cotton underwear
Pat dry, do not rub
Dry with a blow-drier
on cool
Systemic agents
whenever possible
37
Lubricants
• 
• 
• 
• 
• 
• 
Retard evaporation of water
Replace lipids +/Vehicles for medications
Limit friction
Help with reepithelialization and wound healing
Smooth over scale and roughened surfaces
Vulvar Vestibulitis
•  Burning, irritation, rawness
•  Limited to vulvar vestibule
•  Elicited by physical touch or pressure
•  painful foreplay
•  using tampons
•  wearing blue jeans
• vaginal penetration
• wiping with toilet paper
• riding bicycle
38
Severity of Vulvar Vestibulitis
•  Grade I
•  Grade II
•  Grade III
Causes discomfort but
does not prevent intercourse
Frequently prevents
sexual intercourse
Completely prevents sexual
sexual intercourse
Marinoff and Turner, Dermatol Clin, 1992
Pain Medications
Tricyclic Antidepressants
•  Amitriptyline (Elavil ®) (10mg, 25mg, 75mg)
•  Begin at 1/2 a tab qHS and increase slowly as
tolerated to a maximum dose of 75 mg
•  Limit drowsiness by taking it early in evening
•  Xerostomia and xerophthalmia
•  Appetite stimulation
•  Desipramine (Norpramin ®) (25mg,100mg)
•  Less sedating
•  Anxiety and jitteriness
•  Cardiac arrhythmias
39
Pain Medications
Anticonvulsant
•  Gabapentin (Neurontin®) (100mg, 300mg, 400mg)
•  300mg TID
•  Dizziness, somnolence, fatigue, ataxia
•  Pancreatic acinar CA, a rare tumor, was seen in
male rats
•  Negative Ames test
Pitfalls of Treatment
•  Progressive scarring
•  Secondary infection
•  Candidiasis – common
given use of steroids
•  Herpes – reactivation
•  Postinflammatory
hyperpigmentation
40